Haploidentical Stem Cell Transplantation Using PTCY Platform in Paediatric Patients with High-Risk Neuroblastoma

Key Points

• Outcomes indicate a significant improvement in pediatric patients after haploidentical stem cell transplantation.
• The analysis observed a 30% increase in survival rates compared to previous modalities.
• Haploidentical stem cell transplantation was conducted using the PTCY platform to mitigate graft-versus-host disease.
• These findings suggest the PTCY method may lead to enhanced treatments for high-risk neuroblastoma cases.